Cat. No. 2978
Chemical Name: 4-[4-[(5-Nitro-2-furanyl)methylene]
Biological ActivityCell-permeable, irreversible ubiquitin-activating enzyme (E1) inhibitor (IC50 < 10 μM). Blocks ubiquitylation and prevents ubiquitin-mediated proteasomal degradation. Inhibits NF-κB activation, blocks degradation of p53, increases p21 levels and induces apoptosis in vitro. Also causes an increase in sumoylation of proteins.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Brahemi et al (2010) Homology modelling of human E1 ubiquitin activating enzyme. Lett.Drug Des.Discov. 7 57. PMID: 20396627.
Mi et al (2009) Cancer preventative isothiocyanates induce selective degradation of cellular α- and β-tubulins by proteasomes. J.Biol.Chem. 284 17039. PMID: 19339240.
Yang et al (2007) Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res. 67 9472. PMID: 17909057.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses PYR 41 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: PYR 41, supplier, PYR41, ubiquitin-activating, enzyme, E1, inhibitors, inhibits, ubiquitylation, post-translational, modifications, proteasomal, proteasome, sumoylation, sumo, ubiquitin, Tocris Bioscience, Ubiquitin-activating Enzyme E1 Inhibitor products
Find multiple products by catalog number
New Products in this Area
Cdc20 inhibitor; inhibits Cdc20-substrate interactionCC 0651
Allosteric inhibitor of hCdc34N106
Activator of SUMO-activating enzyme, E1 ligase
October 30 - November 3, 2016
Boston, MA, USA